Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan L Boudreau

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
RNA (New York, N.Y.)|August 14, 2008
Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAsRyan L Boudreau, Alex Mas Monteys, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2014
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapyMegan S Keiser, Ryan L Boudreau, Beverly L Davidson
Molecular Therapy. Nucleic Acids|March 14, 2022
Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's diseaseColleen S Stein, Jared M McLendon, Nathan H Witmer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2025
Basic Science and PathogenesisGrace Rocco, Henry Lin, Kailey A Said, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Molecular Therapy. Nucleic Acids|April 8, 2015
Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In VivoAlex Mas Monteys, Matthew J Wilson, Ryan L Boudreau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7Pavitra S Ramachandran, Ryan L Boudreau, Kellie A Schaefer, et al.
Molecular Therapy. Nucleic Acids|December 19, 2023
Modulation of miR-29 influences myocardial compliance likely through coordinated regulation of calcium handling and extracellular matrixXiaoming Zhang, Jared M McLendon, Bailey D Peck, et al.
Journal of Molecular and Cellular Cardiology|February 26, 2025
Gain and loss of the centrosomal protein taxilin-beta influences cardiac proteostasis and stressJared M McLendon, Xiaoming Zhang, Colleen S Stein, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Mitoregulin supports mitochondrial membrane integrity and protects against cardiac ischemia-reperfusion injuryColleen S Stein, Xiaoming Zhang, Nathan H Witmer, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
RNA (New York, N.Y.)|August 14, 2008
Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAsRyan L Boudreau, Alex Mas Monteys, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2014
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapyMegan S Keiser, Ryan L Boudreau, Beverly L Davidson
Molecular Therapy. Nucleic Acids|March 14, 2022
Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's diseaseColleen S Stein, Jared M McLendon, Nathan H Witmer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2025
Basic Science and PathogenesisGrace Rocco, Henry Lin, Kailey A Said, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Molecular Therapy. Nucleic Acids|April 8, 2015
Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In VivoAlex Mas Monteys, Matthew J Wilson, Ryan L Boudreau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7Pavitra S Ramachandran, Ryan L Boudreau, Kellie A Schaefer, et al.
Molecular Therapy. Nucleic Acids|December 19, 2023
Modulation of miR-29 influences myocardial compliance likely through coordinated regulation of calcium handling and extracellular matrixXiaoming Zhang, Jared M McLendon, Bailey D Peck, et al.
Journal of Molecular and Cellular Cardiology|February 26, 2025
Gain and loss of the centrosomal protein taxilin-beta influences cardiac proteostasis and stressJared M McLendon, Xiaoming Zhang, Colleen S Stein, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Mitoregulin supports mitochondrial membrane integrity and protects against cardiac ischemia-reperfusion injuryColleen S Stein, Xiaoming Zhang, Nathan H Witmer, et al.
Pageof 7